Nuclear IL-33 is a transcriptional regulator of NF-κB p65 and induces endothelial cell activation

Biochemical and Biophysical Research Communications

Volumn 421, Issue 2, 2012, Pages 305-311

  Choi, Yeon Sook ^a   Park, Jeong Ae ^a   Kim, Jihye ^a   Rho, Seung Sik ^a   Park, Hyojin ^a   Kim, Young Myeong ^b   Kwon, Young Guen ^a  

^a Yonsei University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Cell adhesion molecules; High endothelial venules; Inflammation; Interleukin 33; NF B p65; NF HEV

Indexed keywords

BETA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 33; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL ADHESION; CELL NUCLEUS; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKINS; MONOCYTES; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84860477760     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.005     Document Type: Article

References (26)

1. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
2. Pober J.S., Sessa W.C. Evolving functions of endothelial cells in inflammation. Nature Reviews Immunology 2007, 7:803-815.
3. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
4. Baekkevold E.S., Roussigné M., Yamanaka T., Johansen F.E., Jahnsen F.L., Amalric F., Brandtzaeg P., Erard M., Haraldsen G., Girard J.P. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. American Journal of Pathology 2003, 163:69-79.
5. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., Kastelein R.A. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
6. Cayrol C., Girard J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:9021-9026.
7. Palmer G., Gabay C. Interleukin-33 biology with potential insights into human diseases. Nature Reviews Rheumatology 2011, 7:321-329.
8. Kuchler A.M., Pollheimer J., Balogh J., Sponheim J., Manley L., Sorensen D.R., De Angelis P.M., Scott H., Haraldsen G. Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation. American Journal of Pathology 2008, 173:1229-1242.
9. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., Bouche G., Girard J.P. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:282-287.
10. Roussel L., Erard M., Cayrol C., Girard J.P. Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Reports 2008, 9:1006-1012.
11. Maeng Y.S., Min J.K., Kim J.H., Yamagishi A., Mochizuki N., Kwon J.Y., Park Y.W., Kim Y.M., Kwon Y.G. ERK is an anti-inflammatory signal that suppresses expression of NF-kappaB-dependent inflammatory genes by inhibiting IKK activity in endothelial cells. Cellular Signalling 2006, 18:994-1005.
12. Frank P.G., Lisanti M.P. ICAM-1: role in inflammation and in the regulation of vascular permeability. American Journal of Physiology. Heart and Circulatory Physiology 2008, 295:H926-H927.
13. von Andrian U.H., Mempel T.R. Homing and cellular traffic in lymph nodes. Nature Reviews Immunology 2003, 3:867-878.
14. Demyanets S., Konya V., Kastl S.P., Kaun C., Rauscher S., Niessner A., Pentz R., Pfaffenberger S., Rychli K., Lemberger C.E., de Martin R., Heinemann A., Huk I., Groger M., Maurer G., Huber K., Wojta J. Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:2080-2089.
15. Landis R.C., McDowall A., Holness C.L., Littler A.J., Simmons D.L., Hogg N. Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3. Journal of Cell Biology 1994, 126:529-537.
16. Yusuf-Makagiansar H., Anderson M.E., Yakovleva T.V., Murray J.S., Siahaan T.J. Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Medicinal Research Reviews 2002, 22:146-167.
17. Chen L.F., Greene W.C. Shaping the nuclear action of NF-kappaB. Nature Reviews Molecular Cell Biology 2004, 5:392-401.
18. Miyasaka M., Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nature Reviews Immunology 2004, 4:360-370.
19. Miller A.M., Xu D., Asquith D.L., Denby L., Li Y., Sattar N., Baker A.H., McInnes I.B., Liew F.Y. IL-33 reduces the development of atherosclerosis. Journal of Experimental Medicine 2008, 205:339-346.
20. Renne R., Barry C., Dittmer D., Compitello N., Brown P.O., Ganem D. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. Journal of Virology 2001, 75:458-468.
21. Werman A., Werman-Venkert R., White R., Lee J.K., Werman B., Krelin Y., Voronov E., Dinarello C.A., Apte R.N. The precursor form of IL-1α is an intracrine proinflammatory activator of transcription. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2434-2439.
22. Brickman J.M., Adam M., Ptashne M. Interactions between an HMG-1 protein and members of the Rel family. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:10679-10683.
23. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
24. Ueberla K., Lu Y., Chung E., Haseltine W.A. The NF-kappa B p65 promoter. Journal of Acquired Immune Deficiency Syndromes 1993, 6:227-230.
25. Gu L. MDM2 induces NF-kappa B/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood 2002, 99:3367-3375.
26. Yurochko A.D., Mayo M.W., Poma E.E., Baldwin A.S., Huang E.S. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters. Journal of Virology 1997, 71:4638-4648.